NYSE · COO
Healthcare · Medical - Instruments & Supplies
$54.37
Up+$0.07 (+0.13%)
Updated Oct 10, 2026, 10:45 PM
SID Score
4.2/10
Composite research score
Smart Money
62/100
Neutral
Price performance · COO
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
COO closed at $54.37 after 21 trading sessions, up 0.85% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $54.32 | $54.75 | $53.85 | $54.37 | 3.18M |
| Oct 8, 2026 | $54.09 | $54.675 | $53.71 | $54.30 | 5.85M |
| Oct 7, 2026 | $56.33 | $56.495 | $54.66 | $54.75 | 4.55M |
| Oct 6, 2026 | $56.68 | $56.93 | $55.64 | $56.43 | 4M |
| Oct 5, 2026 | $56.37 | $57.01 | $55.73 | $56.77 | 3.95M |
| Oct 2, 2026 | $57.52 | $57.685 | $56.72 | $56.91 | 3.31M |
| Oct 1, 2026 | $56.46 | $57.55 | $55.95 | $57.41 | 4.9M |
| Sep 30, 2026 | $56.62 | $57.37 | $56.36 | $56.53 | 4.89M |
| Sep 29, 2026 | $56.23 | $56.74 | $55.84 | $56.63 | 5.4M |
| Sep 28, 2026 | $55.08 | $56.87 | $54.63 | $56.57 | 4.73M |
| Sep 25, 2026 | $55.18 | $56.176 | $55.02 | $55.38 | 4.45M |
| Sep 24, 2026 | $56.06 | $56.64 | $54.85 | $55.38 | 6.25M |
| Sep 23, 2026 | $55.13 | $56.08 | $54.56 | $56.07 | 4.14M |
| Sep 22, 2026 | $54.21 | $55.49 | $54.075 | $55.29 | 2.69M |
| Sep 21, 2026 | $55.13 | $55.53 | $54.10 | $54.12 | 4.19M |
| Sep 18, 2026 | $54.495 | $55.92 | $54.095 | $55.29 | 8.8M |
| Sep 17, 2026 | $54.82 | $54.82 | $52.78 | $53.775 | 5.71M |
| Sep 16, 2026 | $54.37 | $55.1165 | $53.92 | $54.61 | 5.31M |
| Sep 15, 2026 | $54.40 | $54.80 | $52.965 | $53.27 | 4.42M |
| Sep 14, 2026 | $54.78 | $54.99 | $53.595 | $54.22 | 5.41M |
| Sep 11, 2026 | $54.66 | $55.66 | $53.15 | $53.91 | 6.44M |
The latest Smart Investors Daily articles mentioning COO.
Company
Market Activity
Research & News
COO research
Company profile and research snapshot.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 7, 2026 | Barclays | Equal-Weight | — |
| Sep 15, 2026 | Needham | Buy | — |
| Sep 11, 2026 | Mizuho | Outperform | — |
| Sep 10, 2026 | JP Morgan | Neutral | — |
| Sep 10, 2026 | Piper Sandler | Neutral | — |
No generated briefing is available yet.
Yahoo · Oct 2, 2026
Insider doubled down after stock fell 16% over the past year, signaling confidence in the contact lens and surgical care provider's recovery prospects.
Yahoo · Oct 1, 2026
New research from CooperVision reveals that vision remains an overlooked, yet high potential part of the healthy aging conversation as consumers increasingly invest in products and services that help them look and feel younger. The Unmet Opportunities: Multifocal Contact Lenses and the Anti-Aging Movement (U.S.) report highlights evolving attitudes towards aging and receptiveness to multifocal contact lenses, revealing largely untapped opportunities for eye care professionals (ECPs) to introduce
Yahoo · Sep 29, 2026
New facility expands hands-on learning opportunities and strengthens connections between education, industry and patient care CooperVision Contact Lens Centre of Excellence The new CooperVision Contact Lens Centre of Excellence at Newnham Campus provides students with experiences that reflect today’s evolving eye care environment. TORONTO, Sept. 29, 2026 (GLOBE NEWSWIRE) -- As the demand for vision care continues to grow, preparing the next generation of eye care professionals has never been mor
Yahoo · Sep 28, 2026
Activist campaigns tend to surface when a stock’s performance no longer matches its story, and The Cooper Companies, Inc. (NASDAQ:COO) is a case in point. In mid-September 2026, Jana Partners, which built its stake in the contact lens maker roughly a year ago. It began pushing Cooper to replace CEO Albert White and its board […]
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning COO.
